Диссертация (1154515), страница 19
Текст из файла (страница 19)
Thomas, L. Treatment of fungal UTI / L. Thomas, C.R. Tracy // UrologicClinics of North America. - 2015. - Vol. 42, Issue 4. - P. 473-483.325. Thoureen, T. UTI / T. Thoureen, S. Scott, J. Best, F. Lo Vecchio // AHCMedia.Georgia,USA.-2015.Availableonlinefromhttp://www.ahcmedia.com/articles/135127-urinary-tract-infection326. Thumbikat, P. Bacteria-induced uroplakin signaling mediates bladderresponse to infection / P. Thumbikat, R.E.
Berry, G. Zhou, B.K. Billips, R.E. Yaggie //PLOS Pathogens. - 2009. - Vol. 5. - P. e1000415.327. Touaibia, M. Glycodendrimers as anti-adhesion drugs against type 1fimbriated Escherichia coli uropathogenic infections / M. Touaibia, R. Roy // MiniReviews in Medicinal Chemistry. - 2007. - Vol. 7, № 12. - P. 1270-1283.328. Tsai, K.W. Difference in the regulation of IL-8 expression induced byUPEC between two kinds of urinary tract epithelial cells / K.W. Tsai, H.T. Lai, T.C.Tsai, Y.C. Wu, Y.T.
Yang // Journal of Biomedical Sciences. - 2009. - Vol. 16, № 91. P. 1-14.329. Ugbogu, O. Asymptomatic bacteriuria among pregnant women in Aba / O.Ugbogu, R. Ogbonnaya, O. Nworie // Nigeria Journal of Microbiology. - 2010. - Vol.24. - P. 2024-2027.330. Upadhyay, S. Genetic environment of plasmid mediated CTX-M-15 ESBLsfrom clinical and food borne bacteria in North-Eastern India / S. Upadhyay, A. Hussain,S. Mishra, A.
Maurya, A. Bhattacharjee // PLOS ONE. - 2015. - P. 1-11.104331. Vakulenko, S.B. Versatility of aminoglycosides and prospects for theirfuture / S.B. Vakulenko, S. Mobashery // Clinical Microbiology Reviews. - 2003. - Vol.16, № 3. - P. 430-450.332. Vandepitte, J. Basic laboratory procedures in clinical bacteriology. Part 1:Bacteriological investigations: Urine / J. Vandepitte, J.
Verhaegen, K. Engbaek, P.Rohner, P. Piot // 2nd edition. WHO, Geneva, Switzerland. - 2003. - P. 30-36.333. Vasudevan, R. UTI: An overview of the infection and the associated riskfactors / R. Vasudevan // Journal of Microbiology and Experimentation. - 2014. - Vol. 1,№ 2. - P. 1-15.334. Vincent, M. Helicase-dependent isothermal DNA amplification / M.Vincent, Y. Xu, H. Kong // EMBO Reports. - 2004. - Vol. 5, № 8. - P. 795-800.335. Waheed, L.A.
A colour atlas of medical bacteriology / L.A. Waheed, A.S.David, I.I. Abdullah, M.A. Abass, Z.I. Jassim // Department of teaching laboratories andcentral public health laboratory. Ministry of Health. Baghdad, Iraq. - 2008. - Vol. 35. P. 43-55.336. Watterworth, L., Topp E., Schraft H. Multiplex PCR-DNA probe assay forthe detection of pathogenic Escherichia coli / L. Watterworth, E. Topp, H. Schraft //Journal of Microbiological Methods. - 2005. - Vol.
60, № 1. - P. 93-105.337. Wang, C.H. Cranberry-containing products for prevention of UTIs insusceptible populations: A systematic review and meta-analysis of randomizedcontrolled trials / C.H. Wang, C.C. Fang, N.C. Chen, S.S. Liu, P.H. Yu // Archives ofInternal Medicine. - 2012. - Vol. 172, № 13. - P. 988-996.338. Wagenlehner, F.M.
Diagnosis and management for urosepsis / F.M.Wagenlehner, C. Lichtenstern, C. Rolfes // International Journal of Urology. - 2013. Vol. 20. - P. 963-970.339. Wenz, J.R. Escherichia coli isolates serotypes, genotypes, and virulencegenes and clinical coliform mastitis severity / J.R. Wenz, G.M. Barrington, F.B. Garry,R.P. Ellis, R.J. Magnuson // Journal of Dairy Sciences. - 2006. - Vol. 89. - P. 34083412.105340. Wilson, B.A. Bacterial pathogenesis: A molecular approach.
Chapter 11:Bacterial strategies for evading or surviving host defence systems / B.A. Wilson, A.A.Salyers, D.D. Whitt, M.E. Winkler // 3rd edition. American Society for Microbiology,Washington DC, USA. - 2011. - P. 193-224.341. Wolfe, A.J. Evidence of uncultivated bacteria in the adult female bladder /A.J. Wolfe, E. Toh, N. Shibata // Journal of Clinical Microbiology. - 2012. - Vol. 50. P. 1376-1383.342. World Health Organization (WHO). WHO's first global report on antibioticresistance reveals serious, worldwide threat to public health // WHO. - 2014. Availableonline from http://www.who.int/en343. Wright, K.J. Development of IBCs of UPEC depends on type 1 pili / K.J.Wright, P.C. Seed, S.J.
Hultgren // Cellular Microbiology. - 2007. - Vol. 9. - P. 22302241.344. Yamamoto, S. Molecular epidemiology of UPEC / S. Yamamoto // Journalof Infection and Chemotherapy. - 2007. - Vol. 13. - P. 68-73.345. Yang, L.Y. Development of aminoglycoside antibiotics effective againstresistant bacterial strains / L.Y. Yang // Current Topics in Medicinal Chemistry. - 2010.- Vol.
10, № 18. - P. 1898-1826.346. Yazdi, M. Genotypic versus Phenotypic methods to detect ESBLs in UPEC/ M. Yazdi, A. Nazemi, M. Mirinargasi, M. Jafarpour // Annals of Biological Research.- 2012. - Vol. 3, № 5. - P. 2454-2458.347. Yumuk, Z. Turkey: A further country concerned by community-acquiredEscherichia coli clone O25-ST131 producing CTX-M-15 / Z. Yumuk, G. Afacan, M.H.Nicolas-Chanoine, A. Sotto, J.P. Lavigne // Journal of Antimicrobial Chemotherapy. 2008. - Vol.
62, № 2. - P. 284-288.348. Yun, K.W. Molecular typing of UPEC isolated from Korean children withUTI / K.W. Yun, D.S. Kim, W. Kim, I.S. Lim // Korean Journal of Pediatrics. - 2015. Vol. 58, № 1. - P. 20-27.349. Zalamanovici, T.A. Antimicrobial agents for treating uncomplicated UTI inwomen / T.A. Zalamanovici, H.
Green, M. Paul, J. Yaphe, L. Leibovici // Cochrane106Database Systematic Review. - 2010. - Vol. 10. Available online fromhttps://www.ncbi.nlm.nih.gov/pubmed/20927755350. Zdziarski, J. Molecular basis of commensalism in the urinary tract: Lowvirulence or virulence attenuation / J. Zdziarski, C. Svanborg, B. Wullt, J. Hacker, U.Dobrindt // Infection and Immunity. - 2008. - Vol.
76, № 2. - P. 695-703..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
